Kim Vanuytsel’s work with patient-derived stem cells is reshaping how clinicians think about sickle cell treatment — moving from a narrow set of options toward care that is tailored, safer, and more widely accessible.
Click here to read
HEALTHCITY | By Gina Mantica
May 1, 2026
Dr. Valerie Gouon-Evans is using mRNA and cell-based therapies to restore liver function and promote
Kim Vanuytsel’s work with patient-derived stem cells is reshaping how clinicians think about sickle cell
This past Friday, October 24th, BU GCA & BU The ACCESS Granted Program, had the
What’s the secret to living to 100? Centenarian stem cells could offer clues A bank
My name is Gabrielle. I'm the Administrative Assistant at CReM. Leave us a short message down below. We will get back to you ASAP!
Our research focuses on understanding how lung epithelial progenitors interact with their supportive niche in the contexts of pulmonary disease and repair. We use cell culture, mouse models, and cell engraftment to study and augment these interactions with the ultimate goal of establishing novel therapies for pulmonary disease.
In addition, it is our mission to foster a welcoming and supportive environment, both within our lab and the wider research community, in order to train the next generation of scientists. We strongly believe that a diverse and collaborative community is an essential foundation for exploring the world around us and developing effective treatments for patients.